Migrant Workers' Responses to the COVID-19 Pandemic

April 30, 2021 updated by: Yale-NUS College

Responses of International Migrant Workers to Large-Scale Dormitory Outbreaks of COVID-19: A Population Survey

Rumors circulate widely during public health crises and have deleterious consequences. In this study, we seek to document the base rates of migrant workers' rumor exposure and identify predictors of rumor hearing, sharing and belief.

Study Overview

Status

Completed

Conditions

Detailed Description

Rumors circulate widely during public health crises and have deleterious consequences. Vulnerable populations such as migrant workers tend to lack access to accurate health information, which can put them at higher risk for receiving and spreading misinformation.

In this study, we seek to document (i) the base rates of migrant workers' rumor exposure and (ii) identify predictors of rumor hearing, sharing and belief. These predictors include trust in institutions, risk perceptions, online habits and socio-demographic variables.

Data was taken from the COVID-19 Migrant Health Study, a cross-sectional study of male migrants employed in manual labor jobs within Singapore.

Study Type

Observational

Enrollment (Actual)

1011

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

The study population consist of male migrant workers employed in manual labor jobs within Singapore

Description

Inclusion Criteria:

  • At least 21 years old
  • Holds a government work permit identifying their employment status

Exclusion Criteria:

  • NIL

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Migrant Workers

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Confidence in government
Time Frame: baseline
Participants were asked how confident they were that the government could control the nationwide spread of COVID-19
baseline
Fear for health
Time Frame: baseline
Participants were asked how fearful they were about their health during the COVID-19 situation
baseline
Fear for job
Time Frame: baseline
Participants were asked how fearful they were about their job during the COVID-19 situation
baseline
Degree of exposure to rumours
Time Frame: baseline
We investigated participants' familiarity with five rumors that had been widely spread during the COVID-19 pandemic: (1) drinking water frequently will help prevent infection (COVID-19 prevention); (2) eating garlic can help prevent infection (COVID-19 prevention); (3) the outbreak arose from people eating bat soup (COVID-19 origins); (4) the virus was created in a US lab to affect China's economy (COVID-19 origins); and (5) the virus was created in a Chinese lab as a bioweapon (COVID-19 origins).
baseline
Online habits
Time Frame: baseline
We investigated the number of hours per day that participants' spent checking COVID-19 news and discussing COVID-19 on social media.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Yale-NUS College

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 22, 2020

Primary Completion (Actual)

October 11, 2020

Study Completion (Actual)

October 11, 2020

Study Registration Dates

First Submitted

January 20, 2021

First Submitted That Met QC Criteria

January 20, 2021

First Posted (Actual)

January 22, 2021

Study Record Updates

Last Update Posted (Actual)

May 6, 2021

Last Update Submitted That Met QC Criteria

April 30, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 510d2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Due to stipulations by the Institutional Review Board, data cannot be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronavirus

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe